How to utilize skin microbiome research in cosmetic product development?

How to utilize skin microbiome research in cosmetic product development?

17 Oct 2018, 15:00 - 17:00

Marketing Trends & Regulations Theatre 2
Language:
English

Moderated by Nava Dayan Ph. D., Dr. Nava Dayan LLC

The skin microbiome, the population of resident and transient microorganisms in our skin such as viruses, bacteria fungi and mites is a growing area of interest. The identification, classification, mapping, diversity, environmental implications and inferences to skin condition are key areas of investigation.

Various molecular and in silico methods are developed yet the path to utilizing this knowledge in skincare is limited.

Gaps in understanding include: baseline, implications in clinical manifestation, selection of appropriate controls in studies, sampling methods, sampling storage, contamination sources, quantification, statistical significance calculation.

This session will provide insights into research and development aspects that may shed light on potential paths to market.

15:00 - 15:30     Introduction to skin microbiome research- limitations and opportunities
Nava Dayan Ph.D.Dr. Nava Dayan LLC

Advances in identification, sequencing and mapping of skin microbiome techniques gave rise to a desire to utilize the knowledge in product development. This talk will describe key aspects in challenges and opportunities associated with bridging science into business.

15:30 - 16:00     National advertising division cases on probiotics and prebiotics
Annie M. Ugurlayan, Assistant Director, National Advertising Division of the Advertising Self-Regulatory Council

This talk will cover NAD’s review of claims touting the benefits of probiotics and prebiotics in foods and dietary supplements and implications for claims for cosmetics products.

16:00 - 16:30     Skin Microbiome and Cosmetics
Kausar Malik, Sr. Principal Research Scientist Microbiology Sciences

To understand the impact of long term use of cosmetics on skin microbial community, we conducted a longitudinal study on 150 normal healthy men and women that took place in May of 2017 and May of 2018. In the study, we measured both visible facial features, such as wrinkles, hyperpigmentation, porphyrins, and biophysical skin properties, including barrier function, skin surface pH and elasticity, to explore insights into how the skin microbiome    composition changes with these signs of skin health and to help target the development of microbiome-based beauty products. The study is designed to collect data over a ten-year period to identify the visual signs of skin aging, and wrinkles and shift in natural skin microflora composition.

16:30 - 17:00     Protecting the Intellectual Property of the Skin Microbiome
Jeffrey K. Mills, Ph.D., Esq., Medler Ferro Woodhouse & Mills

The talk will present an overview of how intellectual property can be implemented and leveraged in the development of skin microbiome-based products and services. In addition, a discussion of the particular challenges and strategies related to patenting inventions in the skin microbiome space will be provided.

Contributors

  • Nava Dayan Ph. D

    Moderator

    Owner

    Dr. Nava Dayan LLC

    Nava Dayan Ph.D. Pharm has about 30 years of experience in skin care segment, and has yielded more than 150 publication credits in numerous...

  • Annie M. Ugurlayan

    Speaker

    Assistant Director

    National Advertising Division of the Advertising Self-Regulatory Council

    Annie Ugurlayan is an Assistant Director of Communications at the National Advertising Division of the Advertising Self-Regulatory Council. She...

  • Kausar Malik

    Speaker

    Sr. Principal Research Scientist Microbiology Sciences

    Amway Corporation

    Kausar Malik is Senior Principle Research Scientist at Amway Corporation, Ada, Michigan. Kausar has more than 30 years’ experience in cosmetics...

  • Jeffrey K. Mills, Ph.D., Esq.

    Speaker

    Principal

    Medler Ferro Woodhouse & Mills

    Jeffrey K. Mills, Ph.D. is a Principal with the firm whose practice focuses on nanotechnology, pharmaceutical, drug delivery, biotechnology, and...

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.